United Therapeutics
开盘价
市值
最高价
最低价
收盘价
成交量
市盈率
股息率
United Therapeutics简介
United Therapeutics Corp. 是一家生物技术公司，致力于为慢性病和危及生命的疾病患者开发和商业化产品。其产品包括 Adcirca、Orenitram、Remodulin、TYVASO 和 Unituxin。公司由 Martine A. Rothblatt 于 1996 年 6 月 26 日创立，总部位于马里兰州银泉市。
如何购买 United Therapeutics (UTHR)
登录
1分钟开户
仅需1分钟即可完成账户申请和验证。整个过程完全自助，支持 RockFlow App 和网页端操作。
充值资金
账户验证完成后，您可以使用首选的支付方式向账户充值。
购买 UTHR
通过 RockFlow App 或网页端搜索 UTHR，输入您想要投资的金额，然后点击确认即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.